Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10599352 | Bioorganic & Medicinal Chemistry Letters | 2005 | 4 Pages |
Abstract
An efficient approach was developed to synthesize 2-(2,4,6-trichlorophenylamino)-4-trifluoromethyl-5-aminomethylthiazoles, corticotropin-releasing factor type 1 receptor (CRF1R) antagonists, by monoalkylation of amines with chloromethyl intermediate 5. The effect of variations in aminomethyl side chain of 6 on binding affinity is discussed.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Dmitry Zuev, Jodi A. Michne, Sokhom S. Pin, Jie Zhang, Matthew T. Taber, Gene M. Dubowchik,